New York, July 04, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Digital Pathology Systems Industry” – https://www.reportlinker.com/p05205340/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Digital Pathology Systems Market to Reach $1.2 Billion by 2026

In recent years, digital pathology has been emerging as one of the most promising technologies in clinical pathology and holds tremendous potential in replacing the traditional microscope-based diagnosis in the near future. Recent advancements in digital photography and slide scanning, and the declining prices of digital cameras have been revolutionizing conventional methods for the documentation of pathology findings, and the achievement of collaborative slide review and image analysis. Considerable skill is required to process and stain fluids and tissues for investigation. Digital pathology enables pathologists to collaborate on slide review across laboratories as well as transmit images to other experts for their first readings or second opinions. Digital pathology systems continue to attract attention in various end-use applications such as diagnostic tests, drug discovery & development, education & training, and academic research in human pathology, veterinary pathology, oral pathology and forensic pathology. Within the diagnostics space, digital pathology systems continue gain traction in medical microscopy, blood analysis, biopsy and dissection among others in the diagnosis of physiological disorders, and organic and infectious diseases.

Amid the COVID-19 crisis, the global market for Digital Pathology Systems estimated at US$573.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2026, growing at a CAGR of 13.9% over the analysis period. Device, one of the segments analyzed in the report, is projected to grow at a 13.8% CAGR to reach US$753.1 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 14.6% CAGR for the next 7-year period. This segment currently accounts for a 29.2% share of the global Digital Pathology Systems market.

The U.S. Market is Estimated at $295.3 Million in 2021, While China is Forecast to Reach $102.9 Million by 2026

The Digital Pathology Systems market in the U.S. is estimated at US$295.3 Million in the year 2021. The country currently accounts for a 42.12% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$102.9 Million in the year 2026 trailing a CAGR of 15.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$114.2 Million by the close of the analysis period.

Factors like COVID-19 along with rising cases of cancer and associated need to diagnose patient biopsies are providing a perfect platform for growth of digital pathology. The technology is anticipated to gain considerably from approval of latest digital pathology platforms and tools by the US FDA. Digital pathology is slated to hold a prominent role in cancer care specialties, especially prostate, skin and breast. The technology is finding increasing acceptance across leading healthcare facilities for analysis of patient images and delivery of enhanced pathology services. Digital pathology significantly improves laboratory efficiency, image management, clinical workflows, diagnostic accuracy and revenues. The technology is likely to gain further from increasing integration with AI and other emerging platforms intended to help pathologists in efficiently dealing with large data volumes for faster and accurate diagnostics. The ability of digital pathology systems to enhance operational efficiency, provide novel treatment methods, reduce lab expenses and more importantly improve overall patient care continues to fuel their adoption worldwide. Digital pathology systems also provide accurate pathological assessment, thus enabling proper, timely and cost effective treatment. The growing need for real time access to pathology outcomes constitutes a major driving force for the digital pathology market.

Also, scarcity of skilled pathologists and excess workloads on pathology teams in research labs and hospital setups continue to drive demand for sophisticated pathology systems. Rising preference for computer-aided diagnosis that enables efficient detection of diseases, quantification of risk assessment and disease progression, and evaluation of results at anatomic level is expected to drive demand for digital pathology systems. Rapidly increasing prevalence of various chronic diseases, such as cancer and cardiac diseases, due to an aging population and changing lifestyles are enhancing the need for faster and more reliable testing and diagnosis systems. In particular, the increasing incidence of cancer across the world and the subsequent increase in demand for timely cancer diagnosis and monitoring solutions remains a prime growth factor for the digital pathology systems market. Digital pathology systems have been proven to increase detection rates of cancer in early stages through identification of indicators that may otherwise go undetected through conventional pathology procedures. Also driving growth are factors such as rising awareness about diagnostic technologies and steadily growing disposable incomes of people across developed and developing economies, which will foster demand for digital pathology systems.

By Type, Human Pathology Segment to Reach $1.1 Billion by 2026

Global market for Human Pathology (Type) segment is estimated at US$474.2 Million in 2020, and is projected to reach US$1.1 Billion by 2026 reflecting a compounded annual growth rate of 14.5% over the analysis period. The United States constitutes the largest regional market for Human Pathology segment, accounting for 41.6% of the global sales in 2020. United States is poised to register the fastest compounded annual growth rate of 16.2% over the analysis period, to reach US$565.8 Million by the end of the analysis period.
Select Competitors (Total 74 Featured) –

• 3DHISTECH Ltd.
• Apollo Enterprise Imaging Corp.
• Carl Zeiss AG
• Corista LLC
• Glencoe Software, Inc
• Hamamatsu Photonics K.K.
• Huron Digital Pathology, Inc.
• Indica Labs
• Inspirata Inc
• KANTERON SYSTEMS S.L.U
• KONFOONG BIOTECH INTERNATIONAL CO.,LTD
• Leica Biosystems Nussloch GmbH
• MikroScan Technologies
• Inc.
• Objective Pathology Services
• Olympus Corporation
• OptraSCAN, Inc
• Philips Healthcare
• Proscia Inc
• Sectra AB
• Visiopharm A/S

Read the full report: https://www.reportlinker.com/p05205340/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
Global Venture Capital Investments in Digital Health Startups
(In US$ Billion)
% Share VC Investments by Category for 2020
FDA Temporarily Relaxes Guidelines to Promote Remote Digital
Pathology Services amid COVID-19 Pandemic
COVID-19 Highlights Need to Implement Structured Online
Curriculum for Pathology Training
Future Outlook of Pathology Post-COVID-19
Digital Pathology Systems – Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Digital Pathology: An Introduction
Key Digital Pathology Tools
Market Outlook
US and Europe Maintain Dominance
Emerging Markets to Experience Strong Growth
Scanners Lead Digital Pathology Market
Software Segment Post Strong Growth
Disease Diagnosis: Major Application of Digital Pathology Systems
Telepathology Experiences Strong Growth
Pharmaceutical and Biotechnology Companies: Important End Use
Markets for Digital Pathology
Global Digital Pathology Systems Market by End-Use: 2020
Major Issues Hampering Adoption of Digital Pathology Systems
Competitive Landscape
Market Share of Leading Players in Digital Pathology Systems
Market: 2020E
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Technological Advancements Drive Adoption of Digital Pathology
Systems
Artificial Intelligence (AI) Steps in to Widen the Scope & Span
of Digital Pathology
EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million
for Years 2020 & 2025
Advantages of AI-Powered Digital Pathology
Digital Pathology Benefits Drug Discovery Process
Need for Early Diagnosis Puts Focus on Digital Pathology
Digital Pathology Systems See Fast Paced Adoption in Cancer and
Other Chronic Diseases
Global Cancer Incidence: Number of New Cancer Cases in Million
for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Number of New Cancer Cases and Deaths (in Million) by Region
for 2018
Global New Cancer Cases and Cancer-related Deaths by Cancer
Site (in %) for 2018
Digital Pathology Emerges as a Tool to Reduce Cases of Cancer
Misdiagnoses
Scarcity of Pathologists & Excess Workload on Pathology Labs
Drives Demand for Digital Systems
Clinical Research Continues to be Core Vertical for Digital
Pathology
Digital Imaging and Robotic Light Microscopy Boost Growth
Computational Pathology for Leading-Edge Image Analytics
Cloud Platform Gains Momentum
Telepathology Expected to Pave Way for Pathology Outsourcing to
Developing Nations
Rise in Significance of Personalized Medicine Bodes Well for
Digital Pathology
Global Personalized Medicine Market: Revenues in US$ Million
for the Years 2019 and 2024
Increased Focus on Companion Diagnostics to Benefit Market Growth
Improving Healthcare & Research Expenditure to Support Growth
World Healthcare Expenditure (In US$ Billion) for the Years
2017-2023
Aging Population: A Key Opportunity Indicator
Global Aging Population: Population of 65+ Individuals
(in Thousands) by Region for 2019 and 2030
Global Population of 65+ Individuals as % of Total Population
by Region for 2019 and 2030
Global Cancer Deaths by Age Group (in %) for 2019
Challenges Facing Digital Pathology Systems Market
High Costs
Workflow Integration with Other Related Functions
Other Issues

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Digital Pathology Systems by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Digital Pathology Systems by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 3: World 12-Year Perspective for Digital Pathology
Systems by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2015,
2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Device by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Device by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 6: World 12-Year Perspective for Device by Geographic
Region – Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Software by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Software by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 9: World 12-Year Perspective for Software by Geographic
Region – Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Other Segments by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Other Segments by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 12: World 12-Year Perspective for Other Segments by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Human Pathology by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Human Pathology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 15: World 12-Year Perspective for Human Pathology by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Veterinary Pathology by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Veterinary Pathology by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 18: World 12-Year Perspective for Veterinary Pathology by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2015, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Pharma & Biotech Companies by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Pharma & Biotech Companies
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 21: World 12-Year Perspective for Pharma & Biotech
Companies by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2015, 2021 &
2027

Table 22: World Recent Past, Current & Future Analysis for
Hospitals & Reference Labs by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals & Reference Labs
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 24: World 12-Year Perspective for Hospitals & Reference
Labs by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2015, 2021 &
2027

Table 25: World Recent Past, Current & Future Analysis for
Academic & Research Institutes by Geographic Region – USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Academic & Research
Institutes by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 27: World 12-Year Perspective for Academic & Research
Institutes by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2015, 2021 &
2027

III. MARKET ANALYSIS

UNITED STATES
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in the United States for 2022
(E)
COVID-19 Triggers Demand for Digital Pathology
Market Overview
Increasing Pressure on Pathological Labs: Cornerstone for Growth
Table 28: USA Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Digital Pathology Systems by
Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 30: USA 12-Year Perspective for Digital Pathology Systems
by Segment – Percentage Breakdown of Value Revenues for Device,
Software and Other Segments for the Years 2015, 2021 & 2027

Table 31: USA Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Digital Pathology Systems by
Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 33: USA 12-Year Perspective for Digital Pathology Systems
by Type – Percentage Breakdown of Value Revenues for Human
Pathology and Veterinary Pathology for the Years 2015, 2021 &
2027

Table 34: USA Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Digital Pathology Systems by
End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 36: USA 12-Year Perspective for Digital Pathology Systems
by End-Use – Percentage Breakdown of Value Revenues for Pharma &
Biotech Companies, Hospitals & Reference Labs and Academic &
Research Institutes for the Years 2015, 2021 & 2027

CANADA
Table 37: Canada Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 39: Canada 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 40: Canada Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 42: Canada 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 43: Canada Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 45: Canada 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

JAPAN
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Japan for 2022 (E)
Market Overview
Table 46: Japan Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 48: Japan 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 49: Japan Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 51: Japan 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 52: Japan Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 54: Japan 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

CHINA
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in China for 2022 (E)
Market Overview
Table 55: China Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 57: China 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 58: China Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 60: China 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 61: China Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 63: China 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

EUROPE
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Europe for 2022 (E)
Market Overview
Table 64: Europe Recent Past, Current & Future Analysis for
Digital Pathology Systems by Geographic Region – France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Digital Pathology Systems
by Geographic Region – France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets – Independent Analysis of
Annual Revenues in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 66: Europe 12-Year Perspective for Digital Pathology
Systems by Geographic Region – Percentage Breakdown of Value
Revenues for France, Germany, Italy, UK, Spain, Russia and Rest
of Europe Markets for Years 2015, 2021 & 2027

Table 67: Europe Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 69: Europe 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 70: Europe Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 72: Europe 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 73: Europe Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 75: Europe 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

FRANCE
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in France for 2022 (E)
Table 76: France Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 78: France 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 79: France Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 81: France 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 82: France Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 84: France 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

GERMANY
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Germany for 2022 (E)
Table 85: Germany Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 87: Germany 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 88: Germany Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 90: Germany 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 91: Germany Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 93: Germany 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

ITALY
Table 94: Italy Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Digital Pathology Systems
by Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 96: Italy 12-Year Perspective for Digital Pathology
Systems by Segment – Percentage Breakdown of Value Revenues for
Device, Software and Other Segments for the Years 2015, 2021 &
2027

Table 97: Italy Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Digital Pathology Systems
by Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 99: Italy 12-Year Perspective for Digital Pathology
Systems by Type – Percentage Breakdown of Value Revenues for
Human Pathology and Veterinary Pathology for the Years 2015,
2021 & 2027

Table 100: Italy Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 101: Italy Historic Review for Digital Pathology Systems
by End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 102: Italy 12-Year Perspective for Digital Pathology
Systems by End-Use – Percentage Breakdown of Value Revenues for
Pharma & Biotech Companies, Hospitals & Reference Labs and
Academic & Research Institutes for the Years 2015, 2021 & 2027

UNITED KINGDOM
Digital Pathology Systems Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in the United Kingdom for 2022
(E)
Table 103: UK Recent Past, Current & Future Analysis for
Digital Pathology Systems by Segment – Device, Software and
Other Segments – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Digital Pathology Systems by
Segment – Device, Software and Other Segments Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 105: UK 12-Year Perspective for Digital Pathology Systems
by Segment – Percentage Breakdown of Value Revenues for Device,
Software and Other Segments for the Years 2015, 2021 & 2027

Table 106: UK Recent Past, Current & Future Analysis for
Digital Pathology Systems by Type – Human Pathology and
Veterinary Pathology – Independent Analysis of Annual Revenues
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Digital Pathology Systems by
Type – Human Pathology and Veterinary Pathology Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 108: UK 12-Year Perspective for Digital Pathology Systems
by Type – Percentage Breakdown of Value Revenues for Human
Pathology and Veterinary Pathology for the Years 2015, 2021 &
2027

Table 109: UK Recent Past, Current & Future Analysis for
Digital Pathology Systems by End-Use – Pharma & Biotech
Companies, Hospitals & Reference Labs and Academic & Research
Institutes – Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Digital Pathology Systems by
End-Use – Pharma & Biotech Companies, Hospitals & Reference
Labs and Academic & Research Institutes Markets – Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 111: UK 12-Year Perspective for Digital Pathology Systems
by End-Use – Percentage Breakdown of Value Revenues for Pharma &
Biotech Companies, Hospitals & Reference Labs and Academic &
Research Institutes for the Years 2015, 2021 & 2027

SPAIN
Table 112: Spain Recent Past, Current & Future Analysis for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05205340/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________